SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
tpj12349-sup-0001-FigS1.tifimage/tif457KFigure S1. Structure of SOL1 protein and characterization of its mutants.
tpj12349-sup-0002-FigS2.tifimage/tif11101KFigure S2. Effects of MCLV3 treatment on Col–0 and sol1 mutants.
tpj12349-sup-0003-FigS3.tifimage/tif9014KFigure S3. Effects of CLE19 treatment on Col–0 and sol1 mutants.
tpj12349-sup-0004-FigS4.tifimage/tif9933KFigure S4. Effects of CLE19 over-expression on Col–0 and sol1101.
tpj12349-sup-0005-FigS5.tifimage/tif8722KFigure S5. Effects of CLV3 over-expression on Col–0 and sol1101.
tpj12349-sup-0006-FigS6.tifimage/tif10371KFigure S6. Effects of CLE19ΔR over-expression on Col–0.
tpj12349-sup-0007-FigS7.tifimage/tif11778KFigure S7. Effects of CLE19ΔR over-expression on sol1101.
tpj12349-sup-0008-FigS8.tifimage/tif1979KFigure S8. C–terminal sequences of CLE peptides.
tpj12349-sup-0010-TableS1.tifimage/tif172KTable S1. Effects of the sol1 mutation on carpel number.
tpj12349-sup-0011-TableS2.tifimage/tif551KTable S2. Primers used in this study.
tpj12349-sup-0009-Legends.docxWord document107K 

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.